FDA Releases Draft Guidance on Using Nucleic Acid Tests to Reduce Hepatitis B Virus Transmission from Human Cell Donors

Summary

The Food and Drug Administration (FDA) has released a draft document outlining the use of nucleic acid tests to reduce the risk of hepatitis B virus transmission from human cell donors, with the goal of supplementing previous recommendations for donor testing.